The Centers for Disease Control and Prevention (CDC) and the American Medical Association (AMA) have created a toolkit that health care teams can use as a guide to Screen, Test and Act Today (STAT) by referring patients to in-person or online diabetes prevention programs. You can download a complete …

  FDA Approves Aflibercept for Diabetic Retinopathy in Patients with Diabetic Macular Oedema. The US Food and Drug Administration (FDA) expanded the approved use for aflibercept (Eylea) injection to treat diabetic retinopathy in patients with diabetic macular oedema (DME). Aflibercept is administered by a physician as an injection into the …

It is time to get out your wallets and take out the big bills that you have hiding in the back. Why do you need to do this? Because the cost of poor diabetes care is growing larger every day. For years we have known that patients with diabetes cost more …

About a year ago one of my pharmacist colleagues called me and was complaining about his blood glucose levels. At the age of 37 he had developed diabetes and was placed on metformin. His glucose improved and he went on a wellness program. After three months he had not lost …

David Levy, MD, FRCP Introduction The pharmacological management of blood glucose in type 2 diabetes remains the most contentious area of diabetes management, and although until relatively recently in the USA the only agents to treat blood glucose were insulin and sulphonylureas, this limited repertoire in no way inhibited the controversy, …

It has been two years since the first SGLT-2 inhibitor, canaglifozin, was approved by the FDA. Since that approval, two more drugs in this class have been approved and the acceptance and use by medical professionals has widened. The mechanism of this class is unique as it works directly on …

The recent study “Diet Soda Intake Is Associated with Long-Term Increases in Waist Circumference in a Biethnic Cohort of Older Adults: The San Antonio Longitudinal Study of Aging (SALSA)”1 suffers from several limitations, which likely confound the study’s conclusions. The authors note that the waist circumference (abdominal fat) findings were not …

In the meta-analysis of 14 randomized trials, DPP-4 inhibitors were also found to increase cardiovascular risk slightly while the effect of insulin glargine was neutral…. Data was reviewed from 14 randomized controlled trials of 95,502 patients with or at risk for type 2 diabetes taking new or more intensive glucose-lowering …

A greater muscle to total abdominal area ratio was associated with lower odds of diabetes…. Skeletal muscle loss with diabetes onset is common and low muscle mass can be a potential risk factor for diabetes. Studies show that glucose storage and consumption by lean muscle are important factors when looking …

An increase in polyunsaturated fatty acid intake showed some benefit in pregnant women with GDM as well as the fetus… GDM not only puts mothers at risk but it can also be dangerous for infants. Studies show that more than half of pregnant women with GDM develop overt diabetes within …